Related Experiment Video

Updated: Aug 10, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Mechanisms of hypoxic cell radiosensitization and the development of new sensitizers

I J Stratford

    International Journal of Radiation Oncology, Biology, Physics
    |March 1, 1982
    PubMed

    Insights

    Researchers explored novel radiosensitizers to enhance cancer radiation therapy. New compounds, including nitroaromatic and heterocyclic agents, show promise for improving tumor cell killing, potentially surpassing current treatments like misonidazole (MISO).

    Area of Science:

    • Radiation oncology
    • Medicinal chemistry
    • Cancer research

    Background:

    • Radiation therapy is a cornerstone of cancer treatment.
    • Tumor hypoxia can reduce the effectiveness of radiation.
    • Radiosensitizers aim to enhance radiation's effect on tumor cells.

    Purpose of the Study:

    • To discuss mechanisms of drug-potentiated radiation response.
    • To identify and evaluate novel hypoxic cell radiosensitizers.
    • To explore potential successors to misonidazole (MISO).

    Main Methods:

    • Review of mechanisms involving nitroaromatic and heterocyclic compounds.
    • Examination of compounds based on electron affinity and efficiency.
    • Description of specific novel compounds and their properties.

    Main Results:

    • Identified desmethylmisonidazole and SR 2508 as low-toxicity MISO alternatives.
    • Found compounds more efficient than predicted by electron affinity.
    • Proposed Ro-03-8799 or RSU 1047 for enhanced radiosensitization.

    Conclusions:

    • Nitroaromatic and heterocyclic compounds are effective hypoxic cell radiosensitizers.
    • Novel compounds, particularly ortho-substituted nitroimidazoles and electron-affinic alkylating agents, show significant promise.
    • Development of superior radiosensitizers to misonidazole (MISO) is feasible.

    More Related Videos

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells09:12

    Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

    Published on: June 14, 2024

    Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

    Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

    Published on: May 23, 2025

    Related Concept Videos

    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Bioactivation and Tissue Toxicity01:25

    Bioactivation and Tissue Toxicity

    Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
    Oxygen Requirements and Growth Patterns01:29

    Oxygen Requirements and Growth Patterns

    Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
    Cellular Injury I: Introduction01:00

    Cellular Injury I: Introduction

    Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...